Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic dosesPETERS, J; WELKER, H. A; BULLINGHAM, R et al.European journal of drug metabolism and pharmacokinetics. 1999, Vol 24, Num 2, pp 133-140, issn 0378-7966Article

Prolongation of the PQ interval as a measure of therapeutic inequivalence between two formulations of diltiazemDELLA PASCHOA, O. E; LUCKOW, V; TRENK, D et al.European journal of clinical pharmacology. 1995, Vol 48, Num 1, pp 45-49, issn 0031-6970Article